Cannabinoids and Neuropathic Pain

被引：29
|
作者：
Goya, P. [1 ]
Jagerovic, N. [1 ]
Hernandez-Folgado, L. [1 ]
Martin, M. I. [2 ]
机构：
[1] CSIC, Inst Quim Med, C Juan de la Cierva 3, E-28006 Madrid, Spain
[2] Univ Rey Juan Carlos, Area Farmacol, Fac Ciencias Salud, E-28922 Madrid, Spain
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2003年 / 3卷 / 07期
关键词：
Cannabinoid; neuropathic pain; analgesia;
D O I：
10.2174/1389557033487818
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
After a brief overview of the endocannabinoid system (CB receptors, and endocannabinoids) and of the cannabinergic ligands, some general issues related to cannabinoids and pain are commented. Finally, the most important findings regarding cannabinoids and neuropathic pain are discussed in detail.
引用
收藏
页码：765 / 772
页数：8
相关论文
共 50 条
  • [21] The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain
    Liang, Ying-Ching
    Huang, Chiung-Chun
    Hsu, Kuei-Sen
    NEUROPHARMACOLOGY, 2007, 53 (01) : 169 - 177
  • [22] R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
    Bishay, Philipp
    Schmidt, Helmut
    Marian, Claudiu
    Hauessler, Annett
    Wijnvoord, Nina
    Ziebell, Simone
    Metzner, Julia
    Koch, Marco
    Myrczek, Thekla
    Bechmann, Ingo
    Kuner, Rohini
    Costigan, Michael
    Dehghani, Faramarz
    Geisslinger, Gerd
    Tegeder, Irmgard
    PLOS ONE, 2010, 5 (05):
  • [23] Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
    Meng, Howard
    Johnston, Bradley
    Englesakis, Marina
    Moulin, Dwight E.
    Bhatia, Anuj
    ANESTHESIA AND ANALGESIA, 2017, 125 (05): : 1638 - 1652
  • [24] Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain
    Blanton, Henry L.
    Brelsfoard, Jennifer
    DeTurk, Nathan
    Pruitt, Kevin
    Narasimhan, Madhusudhanan
    Morgan, Daniel J.
    Guindon, Josee
    DRUGS, 2019, 79 (09) : 969 - 995
  • [25] Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain
    Henry L. Blanton
    Jennifer Brelsfoard
    Nathan DeTurk
    Kevin Pruitt
    Madhusudhanan Narasimhan
    Daniel J. Morgan
    Josée Guindon
    Drugs, 2019, 79 : 969 - 995
  • [26] A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation
    Quintero, Jose-Manuel
    Pulido, German
    Giraldo, Luis-Fernando
    Leon, Marta-Ximena
    Diaz, Luis-Eduardo
    Bustos, Rosa-Helena
    PLANTS-BASEL, 2022, 11 (10):
  • [27] Cannabinoids and pain
    Rice, ASC
    Farquhar-Smith, WP
    Bridges, D
    Brooks, JW
    PROCEEDINGS OF THE 10TH WORLD CONGRESS ON PAIN, 2003, 24 : 437 - 468
  • [28] Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain
    Nalli, Yedukondalu
    Dar, Mohd Saleem
    Bano, Nasima
    Rasool, Javeed Ur
    Sarkar, Aminur R.
    Banday, Junaid
    Bhat, Aadil Qadir
    Rafia, Basit
    Vishwakarma, Ram A.
    Dar, Mohd Jamal
    Ali, Asif
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (09) : 1043 - 1046
  • [29] CANNABINOIDS AND SLEEP HEALTH IN PATIENTS WITH CHRONIC NEUROPATHIC PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    McParland, Aidan
    Daniel, Kapustin
    Bhatia, Anuj
    Clarke, Hance
    Aditya, Trivedi
    Brull, Richard
    Singh, Mandeep
    SLEEP, 2021, 44 : A271 - A272
  • [30] Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids
    Wallace, VCJ
    Cottrell, DF
    Brophy, PJ
    Fleetwood-Walker, SM
    JOURNAL OF NEUROSCIENCE, 2003, 23 (08): : 3221 - 3233
12345